본문 바로가기
KERD
논문KCI 등재

급성백혈병 진단검사 결과보고서의 표준 및 지침: 골수검사, 유세포검사, 세포/분자유전검사

Standards and Guidelines for Reporting Diagnostic Test Results in Acute Leukemia Patients: Bone Marrow Examination, Flow Cytometry, and Cytogenetic/ Molecular Genetics Tests

4

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Reports on hematological neoplasms are produced in various formats in different laboratories. For best patient care, standardization of reports adopting a format that provides concise and clear information is necessary. To this end, the Diagnostic Hematology Standardization Committee, or ganized by the Korean Society for Laboratory Hematology, has proposed a standardized format for reporting diagnostic test results for acute leu kemia patients. It is hoped that this standardization will broadly improve communication with clinicians and improve patient care.

Abstract

Reports on hematological neoplasms are produced in various formats in different laboratories. For best patient care, standardization of reports adopting a format that provides concise and clear information is necessary. To this end, the Diagnostic Hematology Standardization Committee, or ganized by the Korean Society for Laboratory Hematology, has proposed a standardized format for reporting diagnostic test results for acute leu kemia patients. It is hoped that this standardization will broadly improve communication with clinicians and improve patient care.

참고문헌 (19)

  1. Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues" (2017), International Agency for Research on Cancer
  2. Sever C, "Bone marrow synoptic reporting for hematologic neoplasms:Guideline from the College of American Pathologists Pathology and Laboratory Quality Center", Arch Pathol Lab Med, 140, pp.932~949 (2016)
  3. Lee SH, "ICSH guidelines for the standardization of bone marrow specimens and reports", Int J Lab Hematol, 30, pp.349~364 (2008)
  4. Wood BL, "2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry : optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia", Cytometry B Clin Cytom, 72, pp.S14~S22 (2007)
  5. Clinical and Laboratory Standards Institute, "Clinical flow cytometric analysis of neoplastic hematolymphoid cells; Approved guideline-Second edition. CLSI document H43-A2", Clinical and Laboratory Standards Institute, ~ (2007)
  6. Claustres M, "Recommendations for reporting results of diagnostic genetic testing(biochemical, cytogenetic and molecular genetic)", Eur J Hum Genet, 22, pp.160~170 (2014)
  7. Mikhail FM, "Section E6. 1–6. 4 of the ACMG technical standards and guidelines : chromosome studies of neoplastic blood and bone marrow–acquired chromosomal abnormalities", Genet Med, 18, pp.635~642 (2016)
  8. 권정아, "말초혈액 혈구 판독 표준안", Laboratory Medicine Online, 9(3), pp.115~125 (2019), 대한진단검사의학회[DOI]
  9. Arber DA, "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia", Blood, 127, pp.2391~2405 (2016)
  10. Béné M, "Immunophenotyping of acute leukemia and lymphoproliferative disorders : a consensus proposal of the European LeukemiaNet Work Package 10", Leukemia, 25, pp.567~574 (2011)
  11. Theunissen P, "Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia", Blood, 129, pp.347~357 (2017)
  12. Wood BL, "Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry", Cytometry B Clin Cytom, 90, pp.47~53 (2016)
  13. Schuurhuis GJ, "Minimal", measurable residual disease in AML : a consensus document from the European LeukemiaNet MRD Working Party, 2018, pp.131, 1275~1291
  14. Rack KA, "European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms", Leukemia, 33, pp.1851~1867 (2019)
  15. McGowan-Jordan J, "ISCN : an international system for human cytogenomic nomenclature(2016)", Cytogenetic and Genome Research, 149, pp.1~2 (2016)
  16. Cross NCP, "Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK", Br J Haematol, 182, pp.777~788 (2018)
  17. Ohgami RS, "Challenges in consolidated reporting of hematopoietic neoplasms", Surg Pathol Clin, 6, pp.795~806 (2013)
  18. Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
  19. Li MM, "Standards and guidelines for the interpretation and reporting of sequence variants in cancer : a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists", J Mol Diagn, 19, pp.4~23 (2017)

관련 논문AI추천

혈액종양의 세계보건기구 분류에 근거한 급성골수성백혈병의 진단적 접근조영욱대한내과학회 · 대한내과학회지2022 · 제97권 제5호혈액종양 초진단 검사항목 지침 개정공선영, 김명신, 김인숙, 남명현, 박효순, 송재우, 이승태, 이자영, 조영욱, 허정원, 허희진대한진단검사의학회 · Laboratory Medicine Online2020 · 제10권 제1호Current Status of Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasms in Korea강은숙, Ahn Ari, Cho Duck, Choi Hyun-Woo, Han Jin-Yeong, Hwang Sang-Hyun, Kim Hyerim, Kim Hyun-Young, Kim Kyeong-Hee, Kim Miyoung, Lim Jihyang, Oh Eun-Jee, Park Joo-Heon, Park Mikyoung, Shin Kyung-Hwa, Song Jaewoo대한진단검사의학회 · Annals of Laboratory Medicine2024 · 제44권 제3호혈액종양 초기진단 검사항목 지침공선영, 김명신, 김선희, 김인숙, 김현경, 이승태, 이영경, 이우인, 이자영, 장윤환, 조영욱, 허정원대한진단검사의학회 · Laboratory Medicine Online2016 · 제6권 제1호혈액종양 진단검사 지침 개정 - 제5판 세계보건기구와 International Consensus Classification 기반Jang Mi-Ae, Kim Hee-Jin, Kim Miyoung, Kim Myungshin, Lee Ja Young, Lee Woo-In, Lee Young Kyung, Nam Myung-Hyun, Park Chang-Hun, Yoon Jong Hyun, Yoon Jung대한진단검사의학회 · Laboratory Medicine Online2025 · 제15권 제2호진단 시 낮은 종양 분율에 의해 유전 검사 위음성을 보인 급성 백혈병 1예: 최신 진단 기준에 비춘 시사점한승민, Ahn Won Kee, Choi Jong Rak, Kim Hongkyung, Lee Jinho, Lee Seung-Tae, Shin Saeam대한진단검사의학회 · Laboratory Medicine Online2024 · 제14권 제3호

이 간행물의 다른 논문 (11건)